Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 23, Number 6—June 2017

Sporadic Creutzfeldt-Jakob Disease in 2 Plasma Product Recipients, United Kingdom

Patrick Urwin, Kumar Thanigaikumar, James W. Ironside, Anna Molesworth, Richard S. Knight, Patricia E. Hewitt, Charlotte Llewelyn, Jan Mackenzie, and Robert G. WillComments to Author 
Author affiliations: University of Edinburgh Western General Hospital, Edinburgh, Scotland, UK (P. Urwin, J.W. Ironside, A. Molesworth, R.S. Knight, J. Mackenzie, R.G. Will); University Hospital Lewisham, London, UK (K. Thanigaikumar); National Health Service Blood and Transplant, London (P.E. Hewitt); National Health Service Blood and Transplant/Public Health England Epidemiology Unit, Cambridge, UK (C. Llewelyn)

Main Article

Table 1

Selected characteristics of blood donors to the patient with sporadic Creutzfeldt-Jakob disease described in case 1, United Kingdom, 2014*

Interval from transfusion to onset, y
No. donors
No. donors alive
No. donors dead
3 RBC LD 4 4 0
6 RBC LD 6 6 0
7 RBC LD 19 19 0
9 RBC LD 3 3 0
10 RBC LD 4 4 0
12 Whole blood LD; RBC LD; platelets LD 2; 27; 42 2; 27; 41 0; 0; 1

*LD, leukodepleted; RBC, red blood cells. Median age of donors, 56 years (range 27–80 years).

Main Article

Page created: May 11, 2017
Page updated: May 11, 2017
Page reviewed: May 11, 2017
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.